National Patterns of Care and Fertility Outcomes for Reproductive-aged Women with Endometrial Cancer or Atypical Hyperplasia.
Sign Up to like & getrecommendations! Published in 2019 at "American journal of obstetrics and gynecology"
DOI: 10.1016/j.ajog.2019.05.029
Abstract: BACKGROUND While uncommon, the incidence of endometrial cancer and atypical hyperplasia among reproductive-aged women is increasing. The fertility outcomes in this population are not well described. OBJECTIVES We aim to describe the patterns of care… read more here.
Keywords: endometrial cancer; progestin therapy; therapy; atypical hyperplasia ... See more keywords
Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2020-001362
Abstract: Introduction Previous studies have suggested that metformin use may enhance the therapeutic effect of progestin therapy for endometrial hyperplasia or malignancy. However, it is not known how the impact of concurrent metformin may be altered… read more here.
Keywords: concurrent metformin; intrauterine device; progestin; progestin therapy ... See more keywords